Autoimmune Diseases, the Impact of COVID-19 and Vaccine Development Make an Appointment Ask a Question Search Conditions Since the early 1980s when they and others discovered the T-cell receptor, the crucial immune-system element that recognizes foreign substances in the body, National Jewish Health scientists and world-renowned immunologists Drs. Philippa Marrack and John Kappler have continued to make significant contributions to our understanding of disease, leading to better therapies for cancer, allergies and other infections. Find out how their current work is helping us move closer to cures and treatments for immune-related lung diseases including scleroderma and sarcoidosis, as well as type 1 diabetes, lupus, multiple sclerosis and more. They will also give an update on the impact of COVID-19 on autoimmune diseases and the importance of delivering a safe and effective COVID-19 vaccine. To sign up for future Dialogue with a Doc discussions, please visit njhealth.org/DocSeries. Related Videos COVID-19 and Respiratory Illness: A Research & Treatment Update Asthma Research & Treatment and COVID-19 Advancements in Childhood and Adult Allergy Research and Treatment Chronic Obstructive Pulmonary Disease (COPD) and the Impact of COVID-19 Cardiology and the Impact of COVID-19: The Link Between the Heart and the Lung Nontuberculous Mycobacteria (NTM), Bronchiectasis and COVID-19: Research and Treatment Update Gastroenterology: The Gut, the Lung and Beyond Heart Health: Prevention, Lifestyle and Wellness Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF) Exercise Intolerance: Breathing Trouble When Exercising COVID-19 Update: What We Know and the Answers We Seek The Intersection of Autoimmune Diseases and the Lung Making Strides in the Treatment of Cystic Fibrosis Big Impact Ideas: Our Next Life-Changing Discoveries Want to use this on your website? Fill out the content usage request form and then copy this code: